This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 May-Jun;142(3):68-9.

Intradermal injection of reduced-dose influenza vaccine was immunogenic in young adults

Joanne M Langley¹

Affiliations

PMID: 15862068

Comment

Intradermal injection of reduced-dose influenza vaccine was immunogenic in young adults

Joanne M Langley. ACP J Club. 2005 May-Jun.

. 2005 May-Jun;142(3):68-9.

Author

Joanne M Langley¹

Affiliation

¹ Dalhousie University, Halifax, Nova Scotia, Canada.

PMID: 15862068

No abstract available

PubMed Disclaimer

Comment on

Dose sparing with intradermal injection of influenza vaccine.
Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Kenney RT, et al. N Engl J Med. 2004 Nov 25;351(22):2295-301. doi: 10.1056/NEJMoa043540. Epub 2004 Nov 3. N Engl J Med. 2004. PMID: 15525714 Clinical Trial.

Similar articles

Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y. Van Damme P, et al. Vaccine. 2009 Jan 14;27(3):454-9. doi: 10.1016/j.vaccine.2008.10.077. Epub 2008 Nov 18. Vaccine. 2009. PMID: 19022318 Clinical Trial.
Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
Sugimura T, Ito Y, Tananari Y, Ozaki Y, Maeno Y, Yamaoka T, Kudo Y. Sugimura T, et al. Vaccine. 2008 May 23;26(22):2700-5. doi: 10.1016/j.vaccine.2008.03.016. Epub 2008 Mar 31. Vaccine. 2008. PMID: 18436353 Clinical Trial.
Intradermal injection of reduced-dose influenza vaccine was highly immunogenic in persons </= 60 years of age but less so in persons > 60 years.
Langley JM. Langley JM. ACP J Club. 2005 May-Jun;142(3):68-9. ACP J Club. 2005. PMID: 15862067 No abstract available.
Reduced-dose influenza vaccine.
Wyatt KN, Ryan GJ, Sheerin KA. Wyatt KN, et al. Ann Pharmacother. 2006 Sep;40(9):1635-9. doi: 10.1345/aph.1G645. Epub 2006 Jul 11. Ann Pharmacother. 2006. PMID: 16835314 Review.
Boostrix: a reduced-dose acellular pertussis vaccine for use in adolescents and adults.
Li WC, Wu TZ, Huang YC, Huang LM. Li WC, et al. Expert Rev Vaccines. 2009 Oct;8(10):1317-27. doi: 10.1586/erv.09.96. Expert Rev Vaccines. 2009. PMID: 19803753 Review.

See all similar articles

Cited by

Microneedle and mucosal delivery of influenza vaccines.
Kang SM, Song JM, Kim YC. Kang SM, et al. Expert Rev Vaccines. 2012 May;11(5):547-60. doi: 10.1586/erv.12.25. Expert Rev Vaccines. 2012. PMID: 22697052 Free PMC article. Review.
International Consensus Guidelines on the Safe and Evidence-Based Practice of Mesotherapy: A Multidisciplinary Statement.
Mammucari M, Russo D, Maggiori E, Rossi M, Lugli M, Marzo RD, Migliore A, Leone R, Koszela K, Varrassi G, On Behalf Of The International Expert Panel. Mammucari M, et al. J Clin Med. 2025 Jul 2;14(13):4689. doi: 10.3390/jcm14134689. J Clin Med. 2025. PMID: 40649062 Free PMC article.

Publication types

Actions